Recon: FDA approves Merck’s RSV antibody for infants; Gilead’s HIV combo studies placed on hold

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States